Showing results (1811-1820 of 3,352) with videos related to
Sort By:
Pageof 336
Polymers|October 23, 2021
H+-Conducting Aromatic Multiblock Copolymer and Blend Membranes and Their Application in PEM ElectrolysisJohannes Bender, Britta Mayerhöfer, Patrick Trinke, et al.The Journal of General Virology|February 1, 2003
Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccineTomáš Hanke, Christina Barnfield, Edmund G-T Wee, et al.Molecules (Basel, Switzerland)|March 22, 2020
Systematic Investigation of Insulin Fibrillation on a ChipHoon Suk Rho, Henk-Willem Veltkamp, Alexander Thomas Hanke, et al.Cell and Tissue Research|December 17, 2013
Plerixafor induces the rapid and transient release of stromal cell-derived factor-1 alpha from human mesenchymal stromal cells and influences the migration behavior of human hematopoietic progenitor cellsPatrick Wuchter, Christina Leinweber, Rainer Saffrich, et al.Annals of Human Biology|November 5, 2013
Occupational, life stress and family functioning: does it affect semen quality?J Jurewicz, M Radwan, D Merecz-Kot, et al.Acta Paediatrica (Oslo, Norway : 1992). Supplement|September 27, 2006
Lead neurotoxicity in children: is prenatal exposure more important than postnatal exposure?Roberto Ronchetti, Peter van den Hazel, Greet Schoeters, et al.EFORT Open Reviews|July 16, 2021
Complications of hip preserving surgeryMarkus S Hanke, Till D Lerch, Florian Schmaranzer, et al.Human Genetics|November 6, 2003
Identification of transcripts from a subtraction library which might be responsible for the mild phenotype in an intrafamilially variable course of Duchenne muscular dystrophyMarco Sifringer, Birgit Uhlenberg, Stefanie Lammel, et al.Frontiers in Immunology|June 4, 2019
Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c MiceAthina Kilpeläinen, Narcís Saubi, Núria Guitart, et al.Anesthesiology|October 6, 2011
First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort studyKlaus Görlinger, Daniel Dirkmann, Alexander A Hanke, et al.Pageof 336